Methamphetamine and other ATS remain the leading substances for which people seek drug treatment in East and South-East Asia.The number of people receiving treatment for ATS use, mainly methamphetamine, has remained stable or declined in the majority of reporting countries – with the exception of…
ATS seizures reached a new record high in 2024, dominated by methamphetamine.
The synthetic drugs market in the Near and Middle East remains dynamic, following disruptions in the supply of “captagon”.The Near and Middle East accounted for 77 per cent of global “captagon” seizures in 2020–2024, with production mainly in the Syrian Arab Republic and Lebanon and trafficking…
The use of amphetamines has distinct regional patterns; past-year use is generally higher among men (0.85 per cent) than women (0.34 per cent) globally.The largest markets for ATS, mainly methamphetamine, remain East and South-East Asia and North America. The highest past-year use of amphetamines…
Data show a growing importance of 3,4-MDP-2-P methyl glycidic acid related substances among “ecstasy” precursors and an ongoing concentration of “ecstasy” precursor seizures in Europe.Historically, 3,4-MDP-2-P, also known as piperonyl methyl ketone (PMK), has been the primary precursor chemical…
“Ecstasy” seizures reached record levels in 2024, surpassing pre-COVID-19 pandemic highs.The quantity of “ecstasy” (MDMA) seized worldwide increased by 13 percent from 2023 to 2024, more than doubling compared with 2021 levels following a pandemic-related decline.Increases were widespread in 2024…
Most “ecstasy” found in the global market continues to be produced in Western and Central Europe.Data suggest that the bulk of the "ecstasy" is still being produced in Europe, with 82 per cent of reported countries of transit or departure of seized shipments around the world being from the region.…
“Ecstasy” use remains highest in high income countries and parts of Asia.Past-year use of "ecstasy" globally is estimated at 0.4 per cent among those aged 15-64. Use is higher among men (0.54 per cent) than women (0.26 per cent), but the difference is not as pronounced as for other drugs (for…
ATS seizures and dismantled laboratoriesSeizures of amphetamine-type stimulants (ATS) continue to grow globally, dominated by methamphetamine.Quantities of ATS seized have increased more than for any other drug category, reaching a record 604 tons in 2024; methamphetamine dominates both seizures…
Global methamphetamine seizures reached another record high in 2024, with the highest growth rates reported by so-called emerging markets.East and South-East Asia and North America continue to account for the largest methamphetamine seizures globally, although seizures declined in North America…
There continue to be challenges in the interdiction and reporting of laboratories and precursors as traffickers continue to shift precursors and production locations to avoid interceptionsfor the manufacture of methamphetamine in Europe seems to be largely limited to the Kingdom of the Netherlands…
Seizures of methamphetamine in Asia continue to rise, even as the reported number of dismantled methamphetamine laboratories declines.Methamphetamine seizures in Asia reached a record high in 2024, while the number of dismantled (and reported) methamphetamine laboratories declined to its lowest…
